There Is No Substitute for Effective Education About Biosimilars

Affiliations

¹ Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
² Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
³ Department of Pharmacy, Nationwide Children's Hospital, Columbus, Ohio, USA.
⁴ Crohn's & Colitis Foundation, New York, New York, USA.
⁵ Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Golisano Children's Hospital, Rochester, New York, USA.
⁶ Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
⁷ University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.

Editorial

Ross M Maltz et al. Crohns Colitis 360. 2021.

. 2021 Jul 7;3(4):otab047.

doi: 10.1093/crocol/otab047. eCollection 2021 Oct.

¹ Division of Pediatric Gastroenterology, Hepatology, and Nutrition, Nationwide Children's Hospital, Columbus, Ohio, USA.
² Department of Pediatrics, The Ohio State University Wexner Medical Center, Columbus, Ohio, USA.
³ Department of Pharmacy, Nationwide Children's Hospital, Columbus, Ohio, USA.
⁴ Crohn's & Colitis Foundation, New York, New York, USA.
⁵ Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, Golisano Children's Hospital, Rochester, New York, USA.
⁶ Division of Gastroenterology, Hepatology, and Nutrition, Department of Pediatrics, University of Pittsburgh Medical Center, Pittsburgh, Pennsylvania, USA.
⁷ University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.

No abstract available

References

1. Cholapranee A, Hazlewood GS, Kaplan GG, et al. . Systematic review with meta-analysis: comparative efficacy of biologics for induction and maintenance of mucosal healing in Crohn’s disease and ulcerative colitis controlled trials. Aliment Pharmacol Ther. 2017;45:1291–1302. - PMC - PubMed
1. Neurath MF, Travis SP. Mucosal healing in inflammatory bowel diseases: a systematic review. Gut. 2012;61:1619–1635. - PubMed
1. Ma C, Moran GW, Benchimol EI, et al. . Surgical rates for Crohn’s disease are decreasing: a population-based time trend analysis and validation study. Am J Gastroenterol. 2017;112:1840–1848. - PMC - PubMed
1. Click B, Lopez R, Arrigain S, et al. . Shifting cost-drivers of health care expenditures in inflammatory bowel disease. Inflamm Bowel Dis. 2020;26:1268–1275. - PubMed
1. Brill A, Ippolito B. The economics of biologic drugs: a further response to Bach et al. Health Affairs Blog. 2019. https://www.healthaffairs.org/do/10.1377/hblog20190807.554429/full/ - DOI